LEVOTHYROXINE SODIUM
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2022 | $1,000 | 1 | 1 |
| 2021 | $374,554 | 5 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $374,554 | 5 | 99.7% |
| Consulting Fee | $1,000 | 1 | 0.3% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A RANDOMIZED, OPEN-LABEL, PARALLEL-DESIGN, ONE-PERIOD, TWO TREATMENT, PILOT RELATIVE BIOAVAILABILITY STUDY OF BALOXAVIR MARBOXIL TABLETS, 40 MG MANUFACTURED BY NORWICH PHARMACEUTICALS INC, NY 13815 AND XOFLUZA (BALOXAVIR MARBOXIL) TABLETS, 40 MG MANUFACTURED BY SHIONOGI PHARMA CO., LTD., JAPAN IN HEALTHY ADULT SUBJECTS UNDER FASTING CONDITIONS | Alvogen Inc | $374,554 | 0 |
Top Doctors Receiving Payments for LEVOTHYROXINE SODIUM
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Las Vegas, NV | $374,554 | 5 |
| Irwin Klein | — | New Hyde Park, NY | $1,000 | 1 |
Manufacturing Companies
- Alvogen Inc $374,554
- Amneal Pharmaceuticals LLC $1,000
Product Information
- Type Drug
- Total Payments $375,554
- Total Doctors 1
- Transactions 6
About LEVOTHYROXINE SODIUM
LEVOTHYROXINE SODIUM is a drug associated with $375,554 in payments to 1 healthcare providers, recorded across 6 transactions in the CMS Open Payments database. The primary manufacturer is Alvogen Inc.
Payment data is available from 2021 to 2022. In 2022, $1,000 was paid across 1 transactions to 1 doctors.
The most common payment nature for LEVOTHYROXINE SODIUM is "Unspecified" ($374,554, 99.7% of total).
LEVOTHYROXINE SODIUM is associated with 1 research study, including "A RANDOMIZED, OPEN-LABEL, PARALLEL-DESIGN, ONE-PERIOD, TWO TREATMENT, PILOT RELATIVE BIOAVAILABILITY STUDY OF BALOXAVIR MARBOXIL TABLETS, 40 MG MANUFACTURED BY NORWICH PHARMACEUTICALS INC, NY 13815 AND XOFLUZA (BALOXAVIR MARBOXIL) TABLETS, 40 MG MANUFACTURED BY SHIONOGI PHARMA CO., LTD., JAPAN IN HEALTHY ADULT SUBJECTS UNDER FASTING CONDITIONS" ($374,554).